A001060 Stock Overview
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
JW Pharmaceutical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩29,100.00 |
| 52 Week High | ₩51,470.59 |
| 52 Week Low | ₩20,245.10 |
| Beta | 0.61 |
| 1 Month Change | -11.15% |
| 3 Month Change | -19.17% |
| 1 Year Change | 37.42% |
| 3 Year Change | 4.10% |
| 5 Year Change | -7.97% |
| Change since IPO | 778.66% |
Recent News & Updates
Recent updates
JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality
Mar 21
Is JW Pharmaceutical Corporation (KRX:001060) An Attractive Dividend Stock?
Apr 08How Many JW Pharmaceutical Corporation (KRX:001060) Shares Do Institutions Own?
Mar 13Is JW Pharmaceutical (KRX:001060) Using Too Much Debt?
Feb 15JW Pharmaceutical's(KRX:001060) Share Price Is Down 24% Over The Past Three Years.
Jan 19
Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend
Dec 24Would JW Pharmaceutical Corporation (KRX:001060) Be Valuable To Income Investors?
Nov 30Shareholder Returns
| A001060 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -4.7% | -1.0% | -2.4% |
| 1Y | 37.4% | 4.5% | 1.9% |
Return vs Industry: A001060 exceeded the KR Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: A001060 exceeded the KR Market which returned 1.9% over the past year.
Price Volatility
| A001060 volatility | |
|---|---|
| A001060 Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A001060's share price has been volatile over the past 3 months.
Volatility Over Time: A001060's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 1,127 | Young-Sub Shin | www.jw-pharma.co.kr |
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.
JW Pharmaceutical Corporation Fundamentals Summary
| A001060 fundamental statistics | |
|---|---|
| Market cap | ₩695.13b |
| Earnings (TTM) | ₩37.01b |
| Revenue (TTM) | ₩748.53b |
18.3x
P/E Ratio0.9x
P/S RatioIs A001060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A001060 income statement (TTM) | |
|---|---|
| Revenue | ₩748.53b |
| Cost of Revenue | ₩412.98b |
| Gross Profit | ₩335.54b |
| Other Expenses | ₩298.54b |
| Earnings | ₩37.01b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.59k |
| Gross Margin | 44.83% |
| Net Profit Margin | 4.94% |
| Debt/Equity Ratio | 53.9% |
How did A001060 perform over the long term?
See historical performance and comparison